OS THERAPIES
OS Therapies (OST) is a clinical-stage therapeutics company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS). OS Therapies was launched to meet the significant unmet need for new treatments in cancers of the bone in kids and adults. Osteosarcoma is an extremely challenging and often aggressive cancer that has particular treatment challenges due to location, changing genotypes, and high recurrence rates. At OST, they are trying to answer the calls for new treatments, considering there have been no new treatments for OS in over 30 years.
OS THERAPIES
Industry:
Health Care Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Fairfax, Virginia, United States
Country:
United States
Website Url:
http://www.ostherapies.com
Status:
Active
Total Funding:
7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Typekit Squarespace Twitter CDN
Current Employees Featured
Robert G. Petit Chief Medical & Scientific Officer for OS Therapies @ OS Therapies
Chief Medical & Scientific Officer for OS Therapies
2019-01-01
Paul Romness CEO & Founder @ OS Therapies
CEO & Founder
2017-10-01
Founder
Investors List
Noble Capital Markets
Noble Capital Markets investment in Series A - OS Therapies
Tichenor Ventures
Tichenor Ventures investment in Series A - OS Therapies
Official Site Inspections
http://www.ostherapies.com Semrush global rank: 4.83 M Semrush visits lastest month: 1.86 K
- Host name: 124.152.227.35.bc.googleusercontent.com
- IP address: 35.227.152.124
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "OS Therapies"
Leadership - OS Therapies
At OS Therapies, our leadership team is driven by a shared passion for advancing osteopathic care and promoting holistic well-being. With decades of combined expertise, our leaders are …See details»
OS Therapies - Crunchbase Company Profile & Funding
OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for osteosarcoma.See details»
Learn | OS Therapies
At OST, we are answering the call to develop new treatments, considering there have been no new treatments for OS in over 30 years. OST has expanded the pipeline beyond …See details»
OS Therapies Incorporated (OSTX) Company Profile
15825 Shady Grove Road, Suite 135 Rockville, Maryland 20850 United StatesSee details»
OS Therapies - LinkedIn
OS Therapies is a clinical stage research company focusing on therapeutic treatments for Osteosarcoma, Breast Cancer and other solid tumors with two platform technologies: OST …See details»
Org Chart OS Therapies - The Official Board
Oct 29, 2024 The organizational chart of OS Therapies displays its 9 main executives including Paul Romness, Alan Musso and Robert PetitSee details»
OS Therapies Company Profile 2024: Stock …
OS Therapies General Information Description. OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors.See details»
OS Therapies Completes $6 Million Series A Funding Round - PR …
Apr 20, 2021 For more information, please see the Company's website at www.ostherapies.com. Media Contact: Jack Doll +1-571-243-9455 [email protected] SOURCE OS Therapies. Related …See details»
OS Therapies Company Profile - Office Locations, Competitors
Oct 18, 2024 OS Therapies has 1 employees at their 1 location. See insights on OS Therapies including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
OS Therapies - Overview, News & Similar companies - ZoomInfo
Nov 15, 2024 Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30 NEW YORK--(BUSINESS WIRE)--OS Therapies (NYSE American: OSTX) (“OS Therapies” …See details»
OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans …
Oct 28, 2024 NEW YORK--(BUSINESS WIRE)-- OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate …See details»
OS Therapies Announces Pricing of $6 Million Private Placement
5 days ago For more information, please see the Company's website at www.ostherapies.com. About OS Therapies. OS Therapies is a clinical stage oncology company focused on the …See details»
OS Therapies Announces Positive Clinical Update from Ongoing …
ROCKVILLE, Md., June 03, 2024--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage oncology-focused immunotherapy company developing cancer vaccines and antibody drug …See details»
OS Therapies Accepted Into Johnson & Johnson Innovation - JLABS
ROCKVILLE, Md., August 19, 2024--OS Therapies (NYSE American: OSTX) ("OS Therapies" or "the Company"), an ADC and Immunotherapy research and clinical-stage biopharmaceutical …See details»
OS Therapies Announces Dosing of First Patient in a Phase IIb Trial …
Oct 22, 2021 COG (childrensoncologygroup.org), a member of the NCI National Clinical Trials Network (NCTN), is the world's largest organization devoted exclusively to childhood and …See details»
OS Therapies Announces Last Patient Enrolled in OST-HER2 …
NEW YORK, August 29, 2024--OS Therapies Incorporated (NYSE American: OSTX) ("OS Therapies" or "the Company"), an ADC and Immunotherapy research and clinical-stage …See details»
Osteo-Angels - OS Therapies
Our "Osteo-Angels" represent the courageous souls we've lost in the fight against osteosarcoma. Their resilience fuels our drive to discover better treatments and more clinical successes.See details»
OS Therapies Partners with B2i Digital to Engage with Biotech …
4 days ago For more information, please visit www.ostherapies.com. Forward-Looking Statements. Statements in this press release about future expectations, plans and prospects, …See details»
Pipeline & Technology - OS Therapies
Explore the latest advancements in cancer therapy developed by OSTherapies. Our proprietary technologies, OST-tADC Tunable Drug Conjugates and OST-HER2 LM Vaccine, offer …See details»
OS Therapies | Rockville MD - Facebook
OS Therapies, Rockville, Maryland. 15 likes. OS Therapies (OSTX) is the leading Osteosarcoma biotechnology company.See details»